-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation